JPWO2025216249A1 - - Google Patents

Info

Publication number
JPWO2025216249A1
JPWO2025216249A1 JP2025550679A JP2025550679A JPWO2025216249A1 JP WO2025216249 A1 JPWO2025216249 A1 JP WO2025216249A1 JP 2025550679 A JP2025550679 A JP 2025550679A JP 2025550679 A JP2025550679 A JP 2025550679A JP WO2025216249 A1 JPWO2025216249 A1 JP WO2025216249A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025550679A
Other languages
Japanese (ja)
Other versions
JPWO2025216249A5 (https=
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP2025143813A priority Critical patent/JP7842291B2/ja
Publication of JPWO2025216249A1 publication Critical patent/JPWO2025216249A1/ja
Publication of JPWO2025216249A5 publication Critical patent/JPWO2025216249A5/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2025550679A 2024-04-08 2025-04-08 Pending JPWO2025216249A1 (https=)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025143813A JP7842291B2 (ja) 2024-04-08 2025-08-29 シチジンジリン酸コリン配糖体、組成物、シチジン残基含有化合物の配糖体の製造方法、遺伝子組換え微生物、シチジン残基含有化合物の製造方法、及びシチジン残基含有化合物の配糖体の生成の抑制方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2024062224 2024-04-08
PCT/JP2025/014070 WO2025216249A1 (ja) 2024-04-08 2025-04-08 シチジンジリン酸コリン配糖体、組成物、シチジン残基含有化合物の配糖体の製造方法、遺伝子組換え微生物、シチジン残基含有化合物の製造方法、及びシチジン残基含有化合物の配糖体の生成の抑制方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025143813A Division JP7842291B2 (ja) 2024-04-08 2025-08-29 シチジンジリン酸コリン配糖体、組成物、シチジン残基含有化合物の配糖体の製造方法、遺伝子組換え微生物、シチジン残基含有化合物の製造方法、及びシチジン残基含有化合物の配糖体の生成の抑制方法

Publications (2)

Publication Number Publication Date
JPWO2025216249A1 true JPWO2025216249A1 (https=) 2025-10-16
JPWO2025216249A5 JPWO2025216249A5 (https=) 2026-03-18

Family

ID=97350078

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2025550679A Pending JPWO2025216249A1 (https=) 2024-04-08 2025-04-08
JP2025143813A Active JP7842291B2 (ja) 2024-04-08 2025-08-29 シチジンジリン酸コリン配糖体、組成物、シチジン残基含有化合物の配糖体の製造方法、遺伝子組換え微生物、シチジン残基含有化合物の製造方法、及びシチジン残基含有化合物の配糖体の生成の抑制方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025143813A Active JP7842291B2 (ja) 2024-04-08 2025-08-29 シチジンジリン酸コリン配糖体、組成物、シチジン残基含有化合物の配糖体の製造方法、遺伝子組換え微生物、シチジン残基含有化合物の製造方法、及びシチジン残基含有化合物の配糖体の生成の抑制方法

Country Status (2)

Country Link
JP (2) JPWO2025216249A1 (https=)
WO (1) WO2025216249A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3570441D1 (en) * 1985-01-24 1989-06-29 Neopharmed Spa Acylated derivatives of cytidine-diphosphate-choline, process for their preparation and their therapeutic use
IT1188178B (it) * 1985-07-05 1988-01-07 Bioresearch Spa Sali della citidin-difospocolina particolarmente idonei per uso orale
TW200741005A (en) * 2005-08-10 2007-11-01 Kyowa Hakko Kogyo Kk A purification method of cytidine diphosphate
JP5828634B2 (ja) * 2010-12-24 2015-12-09 花王株式会社 組換え微生物を用いたタンパク質の製造方法
EP4103685A1 (en) * 2020-02-14 2022-12-21 Inbiose N.V. Glycominimized bacterial host cells
CN119286751B (zh) * 2024-12-10 2025-03-18 诸城市浩天药业有限公司 一种生产尿苷二磷酸葡萄糖的基因工程菌及其构建方法与应用

Also Published As

Publication number Publication date
JP7842291B2 (ja) 2026-04-07
WO2025216249A1 (ja) 2025-10-16
JP2026020428A (ja) 2026-02-09

Similar Documents

Publication Publication Date Title
JPWO2025216249A1 (https=)
RU2024106969A3 (https=)
CN308412520S (https=)
CN308412425S (https=)
CN309485200S (https=)
CN308894425S (https=)
CN309645479S (https=)
CN309637704S (https=)
CN309636580S (https=)
CN309596932S (https=)
CN308404128S (https=)
CN309565336S (https=)
CN309128446S (https=)
CN308404118S (https=)
CN308975220S (https=)
CN308763066S (https=)
CN308722783S (https=)
CN308613093S (https=)
CN308454256S (https=)
CN308428279S (https=)
CN308413570S (https=)
CN308413560S (https=)
CN308413550S (https=)
CN308413226S (https=)
CN308412800S (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250829

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251110

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260304